O	0	10	Regulation	Regulation	NN	B-NP
O	11	13	of	of	IN	B-PP
B-Tissue	14	18	skin	skin	NN	B-NP
I-Tissue	19	35	microvasculature	microvasculature	NN	I-NP
O	36	48	angiogenesis	angiogenesis	NN	I-NP
O	48	49	,	,	,	O
B-Cell	50	54	cell	cell	NN	B-NP
O	55	64	migration	migration	NN	I-NP
O	64	65	,	,	,	O
O	66	69	and	and	CC	O
O	70	82	permeability	permeability	NN	B-NP
O	83	85	by	by	IN	B-PP
O	86	87	a	a	DT	B-NP
O	88	96	specific	specific	JJ	I-NP
O	97	106	inhibitor	inhibitor	NN	I-NP
O	107	109	of	of	IN	B-PP
O	110	118	PKCalpha	PKCalpha	NN	B-NP
O	118	119	.	.	.	O

O	120	130	Activation	Activation	NN	B-NP
O	131	133	of	of	IN	B-PP
O	134	141	protein	protein	NN	B-NP
O	142	148	kinase	kinase	NN	I-NP
O	149	150	C	C	NN	I-NP
O	151	152	(	(	(	O
O	152	155	PKC	PKC	NN	B-NP
O	155	156	)	)	)	O
O	157	164	induces	induce	VBZ	B-VP
O	165	175	phenotypic	phenotypic	JJ	B-NP
O	176	183	changes	change	NNS	I-NP
O	184	186	in	in	IN	B-PP
O	187	190	the	the	DT	B-NP
O	191	201	morphology	morphology	NN	I-NP
O	202	204	of	of	IN	B-PP
B-Cell	205	218	microvascular	microvascular	JJ	B-NP
I-Cell	219	230	endothelial	endothelial	JJ	I-NP
I-Cell	231	236	cells	cell	NNS	I-NP
O	237	241	that	that	WDT	B-NP
O	242	248	affect	affect	VBP	B-VP
O	249	254	major	major	JJ	B-NP
O	255	264	functions	function	NNS	I-NP
O	265	267	of	of	IN	B-PP
O	268	271	the	the	DT	B-NP
B-Tissue	272	288	microvasculature	microvasculature	NN	I-NP
O	288	289	.	.	.	O

O	290	295	These	These	DT	B-NP
O	296	305	functions	function	NNS	I-NP
O	306	313	include	include	VBP	B-VP
O	314	317	the	the	DT	B-NP
O	318	323	first	first	JJ	I-NP
O	324	330	stages	stage	NNS	I-NP
O	331	333	of	of	IN	B-PP
O	334	343	sprouting	sprout	VBG	B-VP
O	344	346	in	in	IN	B-PP
O	347	359	angiogenesis	angiogenesis	NN	B-NP
O	359	360	,	,	,	O
B-Cell	361	365	cell	cell	NN	B-NP
O	366	375	migration	migration	NN	I-NP
O	376	385	following	follow	VBG	B-PP
O	386	394	wounding	wounding	NN	B-NP
O	394	395	,	,	,	O
O	396	399	and	and	CC	O
B-Multi-tissue_structure	400	408	vascular	vascular	JJ	B-NP
O	409	421	permeability	permeability	NN	I-NP
O	421	422	.	.	.	O

O	423	426	The	The	DT	B-NP
O	427	435	specific	specific	JJ	I-NP
O	436	443	isoform	isoform	NN	I-NP
O	443	444	(	(	(	I-NP
O	444	445	s	s	NNS	I-NP
O	445	446	)	)	)	O
O	447	449	of	of	IN	B-PP
O	450	453	PKC	PKC	NN	B-NP
O	454	465	responsible	responsible	JJ	B-ADJP
O	466	469	for	for	IN	B-PP
O	470	474	each	each	DT	B-NP
O	475	477	of	of	IN	B-PP
O	478	483	these	these	DT	B-NP
O	484	491	changes	change	NNS	I-NP
O	492	495	has	have	VBZ	B-VP
O	496	499	not	not	RB	I-VP
O	500	504	been	be	VBN	I-VP
O	505	515	previously	previously	RB	I-VP
O	516	526	identified	identify	VBN	I-VP
O	526	527	.	.	.	O

O	528	530	In	In	IN	B-PP
O	531	535	this	this	DT	B-NP
O	536	541	study	study	NN	I-NP
O	541	542	,	,	,	O
O	543	545	we	we	PRP	B-NP
O	546	550	used	use	VBD	B-VP
O	551	554	two	two	CD	B-NP
O	555	567	inflammatory	inflammatory	JJ	I-NP
O	568	574	agents	agent	NNS	I-NP
O	574	575	,	,	,	O
O	576	578	IL	IL	NN	B-NP
O	578	579	-	-	HYPH	O
O	579	584	1beta	1beta	NN	B-NP
O	585	588	and	and	CC	O
O	589	596	phorbol	phorbol	NN	B-NP
O	597	605	myristic	myristic	JJ	I-NP
O	606	613	acetate	acetate	NN	I-NP
O	613	614	,	,	,	O
O	615	617	to	to	TO	B-VP
O	618	626	activate	activate	VB	I-VP
O	627	630	PKC	PKC	NN	B-NP
O	631	639	isozymes	isozyme	NNS	I-NP
O	640	643	and	and	CC	O
O	644	652	specific	specific	JJ	B-NP
O	653	663	inhibitors	inhibitor	NNS	I-NP
O	664	666	of	of	IN	B-PP
O	667	675	PKCalpha	PKCalpha	NN	B-NP
O	676	677	(	(	(	O
O	677	683	Go6976	Go6976	NN	B-NP
O	683	684	)	)	)	O
O	685	688	and	and	CC	O
O	689	696	PKCbeta	PKCbeta	NN	B-NP
O	697	698	(	(	(	O
O	698	706	hispidin	hispidin	NN	B-NP
O	706	707	)	)	)	O
O	708	710	to	to	TO	B-VP
O	711	722	distinguish	distinguish	VB	I-VP
O	723	726	how	how	WRB	B-ADVP
O	727	731	each	each	DT	B-NP
O	732	734	of	of	IN	B-PP
O	735	740	these	these	DT	B-NP
O	741	748	isoform	isoform	NN	I-NP
O	748	749	(	(	(	I-NP
O	749	750	s	s	NNS	I-NP
O	750	751	)	)	)	O
O	752	760	controls	control	VBZ	B-VP
O	761	773	angiogenesis	angiogenesis	NN	B-NP
O	773	774	,	,	,	O
B-Pathological_formation	775	780	wound	wound	NN	B-NP
O	781	788	healing	healing	NN	I-NP
O	788	789	,	,	,	O
O	790	793	and	and	CC	O
O	794	806	permeability	permeability	NN	B-NP
O	806	807	.	.	.	O

O	808	810	In	In	IN	B-PP
O	811	814	all	all	DT	B-NP
O	815	820	cases	case	NNS	I-NP
O	820	821	,	,	,	O
O	822	826	only	only	RB	B-NP
O	827	837	inhibition	inhibition	NN	I-NP
O	838	840	of	of	IN	B-PP
O	841	849	PKCalpha	PKCalpha	NN	B-NP
O	850	859	inhibited	inhibit	VBD	B-VP
O	860	864	each	each	DT	B-NP
O	865	867	of	of	IN	B-PP
O	868	873	these	these	DT	B-NP
O	874	883	functions	function	NNS	I-NP
O	884	888	when	when	WRB	B-ADVP
O	889	897	compared	compare	VBN	B-PP
O	898	900	to	to	TO	B-PP
O	901	904	the	the	DT	B-NP
O	905	915	inhibition	inhibition	NN	I-NP
O	916	918	of	of	IN	B-PP
O	919	926	PKCbeta	PKCbeta	NN	B-NP
O	926	927	.	.	.	O

O	928	938	Additional	Additional	JJ	B-NP
O	939	947	analysis	analysis	NN	I-NP
O	948	950	of	of	IN	B-PP
O	951	954	the	the	DT	B-NP
O	955	964	mechanism	mechanism	NN	I-NP
O	965	967	of	of	IN	B-PP
O	968	974	action	action	NN	B-NP
O	975	977	of	of	IN	B-PP
O	978	984	Go6976	Go6976	NN	B-NP
O	985	986	(	(	(	O
O	986	988	RT	RT	NN	B-NP
O	988	989	-	-	HYPH	B-NP
O	989	992	PCR	PCR	NN	I-NP
O	992	993	,	,	,	O
O	994	1001	Western	Western	JJ	B-NP
O	1002	1007	blots	blot	NNS	I-NP
O	1007	1008	,	,	,	O
O	1009	1012	and	and	CC	O
O	1013	1033	immunohistochemistry	immunohistochemistry	NN	B-NP
O	1033	1034	)	)	)	O
O	1035	1037	of	of	IN	B-PP
O	1038	1041	the	the	DT	B-NP
O	1042	1049	changes	change	NNS	I-NP
O	1050	1052	in	in	IN	B-PP
O	1053	1056	the	the	DT	B-NP
O	1057	1071	phosphorylated	phosphorylate	VBN	I-NP
O	1072	1075	and	and	CC	I-NP
O	1076	1093	nonphosphorylated	nonphosphorylated	JJ	I-NP
O	1094	1099	forms	form	NNS	I-NP
O	1100	1102	of	of	IN	B-PP
O	1103	1111	PKCalpha	PKCalpha	NN	B-NP
O	1112	1114	in	in	IN	B-PP
O	1115	1118	the	the	DT	B-NP
B-Cellular_component	1119	1123	cell	cell	NN	I-NP
I-Cellular_component	1124	1132	membrane	membrane	NN	I-NP
O	1133	1136	and	and	CC	I-NP
B-Organism_substance	1137	1146	cytoplasm	cytoplasm	NN	I-NP
O	1147	1156	confirmed	confirm	VBD	B-VP
O	1157	1160	the	the	DT	B-NP
O	1161	1172	specificity	specificity	NN	I-NP
O	1173	1175	of	of	IN	B-PP
O	1176	1184	PKCalpha	PKCalpha	NN	B-NP
O	1185	1195	inhibition	inhibition	NN	I-NP
O	1196	1198	by	by	IN	B-PP
O	1199	1205	Go6976	Go6976	NN	B-NP
O	1205	1206	.	.	.	O

O	1207	1212	These	These	DT	B-NP
O	1213	1220	studies	study	NNS	I-NP
O	1221	1230	therefore	therefore	RB	B-ADVP
O	1231	1239	indicate	indicate	VBP	B-VP
O	1240	1241	a	a	DT	B-NP
O	1242	1250	specific	specific	JJ	I-NP
O	1251	1254	and	and	CC	O
O	1255	1256	a	a	DT	B-NP
O	1257	1267	regulatory	regulatory	JJ	I-NP
O	1268	1272	role	role	NN	I-NP
O	1273	1275	of	of	IN	B-PP
O	1276	1279	the	the	DT	B-NP
O	1280	1288	PKCalpha	PKCalpha	NN	I-NP
O	1289	1296	isoform	isoform	NN	I-NP
O	1297	1299	in	in	IN	B-PP
O	1300	1305	three	three	CD	B-NP
O	1306	1311	major	major	JJ	I-NP
B-Cell	1312	1323	endothelial	endothelial	JJ	I-NP
I-Cell	1324	1328	cell	cell	NN	I-NP
O	1329	1338	functions	function	NNS	I-NP
O	1339	1343	that	that	WDT	B-NP
O	1344	1347	are	be	VBP	B-VP
O	1348	1357	important	important	JJ	B-ADJP
O	1358	1360	in	in	IN	B-PP
O	1361	1364	the	the	DT	B-NP
O	1365	1376	maintenance	maintenance	NN	I-NP
O	1377	1379	of	of	IN	B-PP
B-Tissue	1380	1393	microvascular	microvascular	JJ	B-NP
O	1394	1405	homeostasis	homeostasis	NN	I-NP
O	1405	1406	.	.	.	O

